lisocabtagene maraleuce (BREYANZI)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

* cell suspension for infusion, 70000000 CELLS/ML[1]

Adverse effects

* boxed warning

Mechanism of action

More general terms

References

  1. 1.0 1.1 RxNorm
  2. Breyanzi prscribing information https://packageinserts.bms.com/pi/pi_breyanzi.pdf